期刊： PEDIATRIC BLOOD & CANCER, 2022; 69 (5)
We report a case series of 14 children with intracranial germ cell tumor and concomitant central diabetes insipidus, who developed hyponatremia second......
期刊： PEDIATRIC BLOOD & CANCER, 2022; 69 (9)
Haploidentical hematopoietic stem cell transplant (haplo-HSCT) provides an important alternative for children and adolescents with acquired severe apl......
期刊： PEDIATRIC BLOOD & CANCER, 2022; 69 (10)
While Wilms tumors are the most frequently detected kidney cancer type in children, extrarenal Wilms tumors (ERWTs) remain rare. This report is the fi......
期刊： PEDIATRIC BLOOD & CANCER, 2022; 69 (8)
The prognosis of patients with T-cell acute lymphoblastic leukemia (T-ALL) has been largely lacked behind than that of patients with B-cell ALL, espec......
期刊： PEDIATRIC BLOOD & CANCER, 2022; 69 (11)
Opsoclonus-myoclonus syndrome (OMS) is a rare neurological disorder. Half of these cases occur in children with neuroblastoma. Neuroblastoma patients ......
期刊： PEDIATRIC BLOOD & CANCER, 2022; 69 (12)
Background Hepatoblastomas (HBs) are malignant liver tumors that most commonly develop in pediatric patients. Microvascular invasion may be a prognosi......
期刊： PEDIATRIC BLOOD & CANCER, 2022; 69 (10)
Background and objectives To investigate the feasibility and safety of ultrasound-guided totally implantable venous access ports (TIVAPs) via the righ......
期刊： PEDIATRIC BLOOD & CANCER, 2021; 68 (10)
Background Two chemotherapeutic agents used widely in pediatric oncology are vincristine (VCR) and doxorubicin (DOX), which may cause neuropathy and m......
期刊： PEDIATRIC BLOOD & CANCER, 2021; 68 (10)
Clinical data of five patients with hepatic metastases of retinoblastoma were analyzed retrospectively (two had bilateral tumors three had unilateral ......
期刊： PEDIATRIC BLOOD & CANCER, 2021; 68 (8)
Objective Cytokine storms are central to the development of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH). Previous studi......
期刊： PEDIATRIC BLOOD & CANCER, 2021; 68 (10)
Background Osteonecrosis is a devastating side effect of acute lymphoblastic leukemia (ALL) therapy. Associations between bone density loss and osteon......
